Search
myeloperoxidase (MPO)
Function:
- part of host defense system of polymorphonuclear leukocytes
- responsible for microbicidal activity against a wide range of organisms
- in stimulated PMN, MPO catalyzes the production of hypohalous acids, primarily hypochlorous acid in physiologic situations, & other toxic intermediates that greatly enhance PMN microbicidal activity
Donor + H2O2 = oxidized donor + 2 H2O
Cl(-) + H2O2 = HOCl + 2 H2O
Cofactor:
- binds 1 Ca+2 per heterodimer
- binds 1 heme B (iron-protoporphyrin IX) group covalently per heterodimer
Structure:
- tetramer of two light chains & two heavy chains
- belongs to the peroxidase family. XPO subfamily
Compartment: lysosome
Alternative splicing: named isoforms=3
Pathology:
- defects in MPO are the cause of myeloperoxidase deficiency
- blood levels of myeloperoxidase predictive of adverse coronary outcomes* in patients with chest pain; it is a better predictor than CRP or troponin-T; MPO accumulates in ruptured atheromatous plaques
* myocardial infarction, death
Related
myeloperoxidase antibody in body fluid
myeloperoxidase deficiency
General
Ca+2 binding protein
glycoprotein
peroxidase
Properties
SIZE: entity length = 745 aa
MW = 84 kD
COMPARTMENT: lysosome
MOTIF: signal sequence {1-48}
N-glycosylation site {N139}
cysteine residue {C167}
MODIFICATION: cysteine residue {C180}
cysteine residue {C180}
MODIFICATION: cysteine residue {C167}
heme-binding site [260-260]
histidine residue {H261}
Ca+2-binding site
SITE: 262-262
cysteine residue {C281}
MODIFICATION: cysteine residue {C291}
cysteine residue {C285}
MODIFICATION: cysteine residue {C309}
cysteine residue {C291}
MODIFICATION: cysteine residue {C281}
cysteine residue {C309}
MODIFICATION: cysteine residue {C285}
cysteine residue {C319}
MODIFICATION: cysteine residue {C-INTERCHAIN}
N-glycosylation site {N323}
Ca+2-binding site
SITE: 334-334
Ca+2-binding site
SITE: 336-336
Ca+2-binding site
SITE: 338-338
Ca+2-binding site
SITE: 340-340
N-glycosylation site {N355}
cysteine residue {C387}
MODIFICATION: cysteine residue {C398}
N-glycosylation site {N391}
cysteine residue {C398}
MODIFICATION: cysteine residue {C387}
Transition state stabilizer {405-405}
heme-binding site [408-408]
heme-binding site [409-409]
N-glycosylation site {N483}
Iron [Fe]-binding site
SITE: 502-502
cysteine residue {C606}
MODIFICATION: cysteine residue {C663}
cysteine residue {C663}
MODIFICATION: cysteine residue {C606}
cysteine residue {C704}
MODIFICATION: cysteine residue {C730}
cysteine residue {C730}
MODIFICATION: cysteine residue {C704}
Database Correlations
OMIM correlations
MORBIDMAP 606989
UniProt P05164
Pfam PF03098
Kegg hsa:4353
ENZYME 1.11.1.7
References
- Journal Watch 23(24):191, 2003
Brennan M-L et al, N Engl J Med 349:1595, 2003
PMID: 14573731
- UniProt :accession P05164
- MPObase; Note: MPO mutation db
http://bioinf.uta.fi/MPObase/
- Wikipedia; Note: myeloperoxidase entry
http://en.wikipedia.org/wiki/myeloperoxidase